Articles published by Johnson & Johnson

< Previous 1 2 3 4 5 Next >

Johnson & Johnson to Participate in the 42nd Annual J.P. Morgan Healthcare Conference

December 07, 2023

From Johnson & Johnson

Via Business Wire

Tickers JNJ

Johnson & Johnson Announces Key Drivers for Long-Term Competitive Growth at Enterprise Business Review

December 05, 2023

From Johnson & Johnson

Via Business Wire

Tickers JNJ

Johnson & Johnson Names Eugene A. Woods, Chief Executive Officer of Advocate Health, to its Board of Directors

November 30, 2023

From Johnson & Johnson

Via Business Wire

Tickers JNJ

Johnson & Johnson to Host Enterprise Business Review

November 16, 2023

From Johnson & Johnson

Via Business Wire

Tickers JNJ

Johnson & Johnson Announces Departure of Ashley McEvoy, Tim Schmid Named Executive Vice President, Worldwide Chairman of MedTech

October 23, 2023

From Johnson & Johnson

Via Business Wire

Tickers JNJ

Johnson & Johnson Announces Quarterly Dividend for Fourth Quarter 2023

October 19, 2023

From Johnson & Johnson

Via Business Wire

Tickers JNJ

Johnson & Johnson Reports Q3 2023 Results

October 17, 2023

From Johnson & Johnson

Via Business Wire

Tickers JNJ

Johnson & Johnson to Host Investor Conference Call on Third-Quarter Results

September 18, 2023

From Johnson & Johnson

Via Business Wire

Tickers JNJ

Johnson & Johnson Marks New Era as Global Healthcare Company With Updated Visual Identity

September 14, 2023

From Johnson & Johnson

Via Business Wire

Tickers JNJ

Johnson & Johnson Announces Updated Financials and 2023 Guidance Following Completion of the Kenvue Separation

August 30, 2023

From Johnson & Johnson

Via Business Wire

Tickers JNJ

Johnson & Johnson Announces Final Results of Exchange Offer and Finalizes Separation of Kenvue Inc.

August 23, 2023

From Johnson & Johnson

Via Business Wire

Tickers JNJ KVUE

Johnson & Johnson to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference

August 22, 2023

From Johnson & Johnson

Via Business Wire

Tickers JNJ

Johnson & Johnson Announces Preliminary Results of Kenvue Inc. Exchange Offer

August 21, 2023

From Johnson & Johnson

Via Business Wire

Tickers JNJ KVUE

Johnson & Johnson Announces Final Exchange Ratio of 8.0324 in Split-Off of Kenvue Inc.

August 16, 2023

From Johnson & Johnson

Via Business Wire

Tickers JNJ KVUE

Johnson & Johnson to Participate in the 2023 Wells Fargo Securities Healthcare Conference

August 07, 2023

From Johnson & Johnson

Via Business Wire

Tickers JNJ

Johnson & Johnson Launches Exchange Offer for Separation of Kenvue Inc.

July 24, 2023

From Johnson & Johnson

Via Business Wire

Tickers JNJ

Johnson & Johnson Announces Quarterly Dividend for Third Quarter 2023

July 20, 2023

From Johnson & Johnson

Via Business Wire

Johnson & Johnson Reports Q2 2023 Results

July 20, 2023

From Johnson & Johnson

Via Business Wire

Tickers JNJ

Johnson & Johnson to Participate in the UBS MedTech, Tools and Genomics Summit

July 10, 2023

From Johnson & Johnson

Via Business Wire

Tickers JNJ

Johnson & Johnson to Host Investor Conference Call on Second-Quarter Results

June 06, 2023

From Johnson & Johnson

Via Business Wire

Tickers JNJ

Johnson & Johnson to Participate in the Goldman Sachs 44th Annual Global Healthcare Conference

May 10, 2023

From Johnson & Johnson

Via Business Wire

Tickers JNJ

Johnson & Johnson and Kenvue Announce Pricing of Upsized Kenvue Inc. Initial Public Offering

May 03, 2023

From Johnson & Johnson

Via Business Wire

Tickers JNJ

Johnson & Johnson to Participate in the Bernstein 39th Annual Strategic Decisions Conference

April 25, 2023

From Johnson & Johnson

Via Business Wire

Tickers JNJ

Johnson & Johnson Announces Launch of Kenvue Inc. IPO Roadshow

April 24, 2023

From Johnson & Johnson

Via Business Wire

Tickers JNJ

Johnson & Johnson Announces Dividend Increase of 5.3%

April 18, 2023

From Johnson & Johnson

Via Business Wire

Johnson & Johnson Reports Q1 2023 Results

April 18, 2023

From Johnson & Johnson

Via Business Wire

Tickers JNJ

Johnson & Johnson Subsidiary LTL Management LLC (“LTL”) Re-Files for Voluntary Chapter 11 to Equitably Resolve All Current and Future Talc Claims

April 04, 2023

From Johnson & Johnson

Via Business Wire

Tickers JNJ

Johnson & Johnson to Host Investor Conference Call on First-Quarter Results

March 15, 2023

From Johnson & Johnson

Via Business Wire

Tickers JNJ

Janssen Announces Novel Dengue Antiviral Demonstrates Efficacy in Pre-Clinical Data Published in Nature

March 15, 2023

From Johnson & Johnson

Via Business Wire

Tickers JNJ

Johnson & Johnson Announces Pricing of $7.75 Billion of Senior Notes Issued by Kenvue Inc.

March 08, 2023

From Johnson & Johnson

Via Business Wire

Tickers JNJ

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.